Abstract
Subtle mood fluctuations are normal emotional experiences, whereas drastic mood swings can be a manifestation of bipolar disorder (BPD). Despite their importance for normal and pathological behavior, the mechanisms underlying endogenous mood instability are largely unknown. During embryogenesis, the transcription factor Otx2 orchestrates the genetic networks directing the specification of dopaminergic (DA) and serotonergic (5-HT) neurons. Here we behaviorally phenotyped mouse mutants overexpressing Otx2 in the hindbrain, resulting in an increased number of DA neurons and a decreased number of 5-HT neurons in both developing and mature animals. Over the course of 1 month, control animals exhibited stable locomotor activity in their home cages, whereas mutants showed extended periods of elevated or decreased activity relative to their individual average. Additional behavioral paradigms, testing for manic- and depressive-like behavior, demonstrated that mutants showed an increase in intra-individual fluctuations in locomotor activity, habituation, risk-taking behavioral parameters, social interaction, and hedonic-like behavior. Olanzapine, lithium, and carbamazepine ameliorated the behavioral alterations of the mutants, as did the mixed serotonin receptor agonist quipazine and the specific 5-HT2C receptor agonist CP-809101. Testing the relevance of the genetic networks specifying monoaminergic neurons for BPD in humans, we applied an interval-based enrichment analysis tool for genome-wide association studies. We observed that the genes specifying DA and 5-HT neurons exhibit a significant level of aggregated association with BPD but not with schizophrenia or major depressive disorder. The results of our translational study suggest that aberrant development of monoaminergic neurons leads to mood fluctuations and may be associated with BPD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN et al (2011). Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry 16: 293–306.
Baldacara L, Nery-Fernandes F, Rocha M, Quarantini LC, Rocha GG, Guimaraes JL et al (2011). Is cerebellar volume related to bipolar disorder? J Affect Disord 135: 305–309.
Beaulieu JM (2012). A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci 37: 7–16.
Belmaker RH (2004). Bipolar disorder. N Engl J Med 351: 476–486.
Broccoli V, Boncinelli E, Wurst W (1999). The caudal limit of Otx2 expression positions the isthmic organizer. Nature 401: 164–168.
Brodski C, Weisenhorn DM, Signore M, Sillaber I, Oesterheld M, Broccoli V et al (2003). Location and size of dopaminergic and serotonergic cell populations are controlled by the position of the midbrain-hindbrain organizer. J Neurosci 23: 4199–4207.
Chen G, Henter ID, Manji HK (2010). Translational research in bipolar disorder: emerging insights from genetically based models. Mol Psychiatry 15: 883–895.
Craddock N, Sklar P (2013). Genetics of bipolar disorder. Lancet 381: 1654–1662.
Dao DT, Mahon PB, Cai X, Kovacsics CE, Blackwell RA, Arad M et al (2010). Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol Psychiatry 68: 801–810.
Di Giovanni G, Di Matteo V, Pierucci M, Esposito E (2008). Serotonin-dopamine interaction: electrophysiological evidence. Prog Brain Res 172: 45–71.
Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (2000). Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res 865: 85–90.
Dudok JJ, Groffen AJ, Toonen RF, Verhage M (2011). Deletion of Munc18-1 in 5-HT neurons results in rapid degeneration of the 5-HT system and early postnatal lethality. PLoS One 6: e28137.
Engel SR, Creson TK, Hao Y, Shen Y, Maeng S, Nekrasova T et al (2009). The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry 14: 448–461.
Flaisher-Grinberg S, Einat H (2010). Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine. Front Psychiatry 1: 10.
Fontana R, Della Torre S, Meda C, Longo A, Eva C, Maggi AC (2014). Estrogen replacement therapy regulation of energy metabolism in female mouse hypothalamus. Endocrinology 155: 2213–2221.
Fountoulakis KN, Kontis D, Gonda X, Siamouli M, Yatham LN (2012). Treatment of mixed bipolar states. Int J Neuropsychopharmacol 15: 1015–1026.
Friedman RL, Barrett RJ, Sanders-Bush E (1984). Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. J Pharmacol Exp Ther 228: 628–635.
Gould TD, Einat H (2007). Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neurosci Biobehav Rev 31: 825–831.
Gould TD, O'Donnell KC, Picchini AM, Manji HK (2007). Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32: 1321–1333.
Guiard BP, El Mansari M, Merali Z, Blier P (2008). Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 11: 625–639.
Han K, Holder JL Jr, Schaaf CP, Lu H, Chen H, Kang H et al (2013). SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503: 72–77.
Hegarty SV, Sullivan AM, O'Keeffe GW (2013). Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Dev Biol 379: 123–138.
Kara NZ, Einat H (2013). Rodent models for mania: practical approaches. Cell Tissue Res 354: 191–201.
Kasahara T, Kubota M, Miyauchi T, Noda Y, Mouri A, Nabeshima T et al (2006). Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry 11: 523.
Lee PH, O'Dushlaine C, Thomas B, Purcell SM (2012). INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28: 1797–1799.
Lesch KP, Waider J (2012). Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76: 175–191.
Lucki I, Dalvi A, Mayorga AJ (2001). Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155: 315–322.
McElroy SL, Strakowski SM, Keck PE Jr, Tugrul KL, West SA, Lonczak HS (1995). Differences and similarities in mixed and pure mania. Compr Psychiatry 36: 187–194.
Mukherjee S, Coque L, Cao JL, Kumar J, Chakravarty S, Asaithamby A et al (2010). Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 68: 503–511.
Nestler EJ, Hyman SE (2010). Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161–1169.
Omodei D, Acampora D, Mancuso P, Prakash N, Di Giovannantonio LG, Wurst W et al (2008). Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development 135: 3459–3470.
Pandey A, Davis NA, White BC, Pajewski NM, Savitz J, Drevets WC et al (2012). Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorder. Transl Psychiatry 2: e154.
Pedroso I, Lourdusamy A, Rietschel M, Nothen MM, Cichon S, McGuffin P et al (2012). Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes. Biol Psychiatry 72: 311–317.
Perugi G, Medda P, Reis J, Rizzato S, Giorgi Mariani M, Mauri M (2013). Clinical subtypes of severe bipolar mixed states. J Affect Disord 151: 1076–1082.
Post RM (2007). Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 41: 979–990.
Prakash N, Brodski C, Naserke T, Puelles E, Gogoi R, Hall A et al (2006). A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133: 89–98.
Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011). Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43: 977–983.
Roth B, Hyde E (2000). Pharmacology of 5-HT2 receptors. In: Serotoninergic Neurons and 5-HT Receptors in the CNS Baumgarten HG, Göthert M (eds) Springer-Verlag: Berlin, Heidelberg. pp 367–394.
Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V et al (2007). Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 104: 6406–6411.
Sabunciyan S, Yolken R, Ragan CM, Potash JB, Nimgaonkar VL, Dickerson F et al (2007). Polymorphisms in the homeobox gene OTX2 may be a risk factor for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144B: 1083–1086.
Sanches M, Keshavan MS, Brambilla P, Soares JC (2008). Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog Neuropsychopharmacol Biol Psychiatry 32: 1617–1627.
Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T et al (2008). Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry 13: 858–872.
Siuciak JA, Chapin DS, McCarthy SA, Guanowsky V, Brown J, Chiang P et al (2007). CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity. Neuropharmacology 52: 279–290.
Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K et al (2008). Whole-genome association study of bipolar disorder. Mol Psychiatry 13: 558–569.
Supple WF Jr, Cranney J, Leaton RN (1988). Effects of lesions of the cerebellar vermis on VMH lesion-induced hyperdefensiveness, spontaneous mouse killing, and freezing in rats. Physiol Behav 42: 145–153.
Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J et al (1997). Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54: 37–42.
Tilleman H, Kofman O, Nashelsky L, Livneh U, Roz N, Sillaber I et al (2009). Critical role of the embryonic mid-hindbrain organizer in the behavioral response to amphetamine and methylphenidate. Neuroscience 163: 1012–1023.
Turner CA, Watson SJ, Akil H (2012). The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76: 160–174.
Wang K, Li M, Bucan M (2007). Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81: 1278–1283.
Wei Q, Lu XY, Liu L, Schafer G, Shieh KR, Burke S et al (2004). Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc Natl Acad Sci USA 101: 11851–11856.
Zandi PP, Belmonte PL, Willour VL, Goes FS, Badner JA, Simpson SG et al (2008). Association study of Wnt signaling pathway genes in bipolar disorder. Arch Gen Psychiatry 65: 785–793.
Zhou XH, Brandau O, Feng K, Oohashi T, Ninomiya Y, Rauch U et al (2003). The murine Ten-m/Odz genes show distinct but overlapping expression patterns during development and in adult brain. Gene Expr Patterns 3: 397–405.
Acknowledgements
We thank Galila Agam, Ora Kofman, Haim Einat, Ze’ev Silverman, Marianne B. Muller, and Miroslav Savic for helpful discussion and critical reading of the manuscript. This work was supported by The National Institute for Psychobiology in Israel—Founded by the Charles E. Smith Family (grant 209-11-12 to CB), The Israeli Ministry of Health, Chief Scientist Office (grant 3-7433 to CB), and the Israeli Science Foundation (grant 1391/11 to CB).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Rights and permissions
About this article
Cite this article
Jukic, M., Carrillo-Roa, T., Bar, M. et al. Abnormal Development of Monoaminergic Neurons Is Implicated in Mood Fluctuations and Bipolar Disorder. Neuropsychopharmacol 40, 839–848 (2015). https://doi.org/10.1038/npp.2014.244
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2014.244
This article is cited by
-
Enlightened: addressing circadian and seasonal changes in photoperiod in animal models of bipolar disorder
Translational Psychiatry (2021)
-
Methylation in OTX2 and related genes, maltreatment, and depression in children
Neuropsychopharmacology (2018)
-
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
Molecular Psychiatry (2017)
